TestDynamics Raises $9M in Series A Funding Led by Healthier Capital
Nov 17, 2026 | By Devin Jacobs
SUMMARY
- TestDynamics raised $9 million in Series A funding.
- It will use the funds to improve its AI platform.
- TestDynamics develops AI testing tools for medical imaging.
TestDynamics, an Austin, TX-based provider of a platform for medical imaging, has raised $9 million in a Series A funding round,
The round was led by Healthier Capital with participation from Cedars-Sinai Technology Ventures.
The company will use the funding to expand its clinical validation team, increase deployments across health systems and extend its Satori platform into additional medical imaging specialities.
What is TestDynamics?
Founded by Lior Eshel Ansher, TestDynamics develops technology that helps hospitals and radiologists evaluate, and use artificial intelligence tools in medical imaging.
Read More:Focus Financial Partners Receives Investment From Apollo Funds
Its main product, Satori, is a vendor-neutral platform that works alongside existing medical imaging AI tools. It continuously tests how different algorithms perform on real clinical cases, and compares their results against verified medical findings, known as ground truth.
As more AI tools enter medical imaging, radiologists can receive different findings from multiple systems. Satori aims to simplify this process by evaluating the results and presenting one prioritised reading within the radiologist's existing workflow.
The platform is based on TestDynamics approach called Amalgamated Intelligence. It combines results from different AI systems into a single, independently evaluated output. This helps medical professionals assess AI findings without manually reviewing results from multiple disconnected tools.
How Much Funding Has TestDynamics Raised?
TestDynamics has raised $9 million in its latest Series A funding round.
The company has not disclosed details of previous funding rounds or its total capital raised.
Who Invested in TestDynamics’ Series A?
The $9 million Series A round was led by Healthier Capital.
Cedars-Sinai Technology Ventures also participated in the funding round.
Why the Funding Matters
TestDynamics plans to use the funding to strengthen the clinical validation of its platform, and expand its reach across healthcare organisations.
The company will grow its team responsible for benchmarking AI algorithms against ground truth clinical data. It also plans to expand Satori deployments across more health systems and bring its evaluation and orchestration technology into additional imaging specialities.
The funding comes as hospitals increasingly adopt AI tools for medical imaging. TestDynamics aims to help healthcare providers assess the reliability of these tools, and manage their results through a single platform.
Who founded TestDynamics?
TestDynamics was founded by Lior Eshel Ansher. The company is based in Austin, Texas.
“Evaluation must come from outside the model – continuously, objectively, and measured against both ground truth and competing tools. It cannot come from the vendors themselves. A vendor cannot be expected to self-report that its algorithm underperformed a rival. The referee cannot play for one of the teams,” says Lior Eshel, founder and Chief Executive Officer of TestDynamics.
Market and Business Growth
Satori is already being used clinically at several of the top 10 medical centres in the United States.
The platform is designed to work with AI algorithms from different vendors rather than relying on a single imaging technology provider. It continuously evaluates their performance and directs studies to the tools that perform best.
TestDynamics also points to a 2024 Nature Medicine analysis of FDA authorised AI and machine learning devices, which found that 43% had no published clinical validation data. This highlights the need for independent testing as AI adoption increases in medical imaging.
What Happens Next?
TestDynamics plans to expand it's clinical validation team and increase Satori deployments across additional health systems.
It will also extend the platform into new medical imaging specialities. The company aims to make independent AI evaluation a more integrated part of medical imaging workflows.
Read More:Jacobs appoints Richard Phillips to the Board of Directors









